Skip to main navigation
Skip to search
Skip to main content
University of Applied Sciences Upper Austria Home
Help & FAQ
English
Deutsch
Home
Research units
Profiles
Research output
Projects
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Effect of chronic kidney disease on macrophage cholesterol efflux
Sabine M. Meier
, Anna Wultsch
, Marianne Hollaus
, Markus Ammann
, Elisabeth Pemberger
, Felix Liebscher
, Brigitte Lambers
, Stefanie Fruhwürth
, Tatjana Stojakovic
, Hubert Scharnagl
, Alice Schmidt
, Alexander Springer
, Julia Becker
, Christoph Aufricht
, Ammon Handisurya
, Stefan Kapeller
,
Clemens Röhrl
, Herbert Stangl
*
, Witta Strobl
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of chronic kidney disease on macrophage cholesterol efflux'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cholesterol
100%
Cellular Cholesterol Efflux
100%
Chronic Kidney Disease
100%
Cholesterol Acceptor
71%
High-density Lipoprotein Cholesterol (HDL-C)
57%
Hemodialysis Patients
57%
Macrophages
42%
Export Capacity
42%
Serum Cholesterol
42%
Apolipoprotein A-I (ApoA-I)
28%
Dialysis Patients
28%
Chronic Kidney Disease Stage 3
28%
Older Adults
14%
High Risk
14%
AIMS™
14%
Middle-aged
14%
Atheroprotective Effects
14%
Low Serum
14%
Associated Diseases
14%
Hemodialysis
14%
Renal Transplant Recipients
14%
THP-1 Macrophages
14%
Adaptive Response
14%
Adult Patients
14%
Serum Apolipoproteins
14%
Confounding Factors
14%
Young Adult Patients
14%
Pediatric Patients
14%
Reverse Cholesterol Transport
14%
Transplant Patients
14%
Monocyte-derived Macrophages
14%
Adult Kidney
14%
Medicine and Dentistry
Macrophage
100%
Effusion
100%
Chronic Kidney Disease
100%
Hemodialysis
83%
High-Density Lipoprotein
50%
Apolipoprotein A
33%
Atherosclerosis
16%
Cholesterol Transport
16%
Adaptive Response
16%
Kidney Graft
16%
Middle Age
16%
High Density Lipoprotein Cholesterol
16%
Pediatrics Patient
16%
Immunology and Microbiology
Macrophage
100%
Hemodialysis
83%
High-Density Lipoprotein
66%
Cholesterol Blood Level
50%
Apolipoprotein
33%
Cholesterol Transport
16%
Atherosclerosis
16%
Biochemistry, Genetics and Molecular Biology
Macrophage
100%
Hemodialysis
83%
Cholesterol Blood Level
50%
High-Density Lipoprotein
50%
Apolipoprotein
33%
Adaptive Response
16%
HDL-Cholesterol
16%
Reverse Cholesterol Transport
16%